» Articles » PMID: 11873891

Women Who Are Recalled for Further Investigation for Breast Screening: Psychological Consequences 3 Years After Recall and Factors Affecting Re-attendance

Overview
Specialty Public Health
Date 2002 Mar 5
PMID 11873891
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 1995-1996 a study was commenced investigating the experience of 'false-positive' women, i.e. who had undergone further investigations following routine breast screening and received a clear final result. These women were found to experience significantly greater adverse psychological consequences at 1 month, 5 months and 11 months after assessment compared with women who received a clear result after the initial basic mammogram. The present study follows up these 'false-positive' women 3 years later (at 35 months) just before being invited for their next routine breast screening. It investigates the effect of the previous experience of breast screening on adverse psychological consequences reported by false-positive women at this time, and explores factors that may be associated with the current adverse psychological consequences. Factors influencing attendance for the forthcoming appointment are reported, and the non-attendance rate is monitored.

Methods: Women who had previously completed a questionnaire 1 month, 5 months and 11 months after their last breast screening 3 years ago, were invited to complete a postal questionnaire just before being invited to attend for their next routine mammogram 3 years later. Attendance for this appointment was monitored. A brief questionnaire was sent to non-attenders to ascertain their reasons for not attending.

Results: The response rate was 77 per cent (387/505). Women who, at their last routine breast screening, had received a clear result after fine needle aspiration (FNA) at assessment, after a surgical biopsy or after a 6 month early recall appointment, all suffered significantly greater adverse psychological consequences at 1 month before returning for routine breast screening 3 years later than women who had received a clear result after the initial mammogram at their last routine breast screening. They were between 1.7 and 2 times more likely to suffer psychological consequences than women who received a clear result after their last mammogram. Women who had received a clear result at assessment without undergoing FNA reported higher psychological consequences than those who received a clear result after mammography, but the difference was not significant (relative risk 1.28, 95 per cent confidence interval 0.82-2.00). Fifteen per cent of those who had undergone assessment 3 years earlier did not attend their next routine breast screening appointment compared with 8 per cent of those who received a clear result after mammography (p = 0.035). Factors associated with adverse psychological consequences are reported.

Conclusion: Despite having received a final clear result during their previous routine breast screening 3 years ago, women who had undergone FNA, surgical biopsy or been placed on early recall suffered significantly greater adverse psychological consequences at 1 month before their next routine breast screening appointment than women who had received a clear result after their initial mammogram at their last routine breast screening. Having undergone further investigations did not necessarily motivate women to attend for their next routine appointment, with 15 per cent of these women not returning for routine screening 3 years on.

Citing Articles

The impact of the BreastScreen NSW transition from film to digital mammography, 2002-2016: a linked population health data analysis.

Farber R, Houssami N, McGeechan K, Barratt A, Bell K Med J Aust. 2025; 222(2):82-90.

PMID: 39800865 PMC: 11787811. DOI: 10.5694/mja2.52566.


Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 1: The role of common errors in radiology in missed breast cancer and implications of misdiagnosis.

Thomassin-Naggara I, Kilburn-Toppin F, Athanasiou A, Forrai G, Ispas M, Lesaru M Eur Radiol. 2024; .

PMID: 39545978 DOI: 10.1007/s00330-024-11128-1.


Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.

Mittmann N, Blackmore K, Seung S, Diong C, Done S, Chiarelli A Curr Oncol. 2023; 30(9):8550-8562.

PMID: 37754535 PMC: 10529052. DOI: 10.3390/curroncol30090620.


Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms.

Farber R, Houssami N, Barnes I, McGeechan K, Barratt A, Bell K Int J Environ Res Public Health. 2022; 19(22).

PMID: 36429373 PMC: 9691207. DOI: 10.3390/ijerph192214647.


Experiences of Women Who Refuse Recall for Further Investigation of Abnormal Screening Mammography: A Qualitative Study.

Sung W, Yang H, Liao I, Su Y, Chen F, Chen S Int J Environ Res Public Health. 2022; 19(3).

PMID: 35162064 PMC: 8834256. DOI: 10.3390/ijerph19031041.